- Home
- Equipment
- asia middle east
- inflammation immunity
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Inflammation Immunity Equipment Supplied In Asia Middle East
4 equipment items found
Premium
Manufactured by:Bertin Technologies based inMontigny-le-Bretonneux, FRANCE
Myelotracker® is an innovative fluorescent tool designed to easily identify neutrophils, key cells of the immune system, in blood and tissues. It provides researchers with a reliable solution for studying inflammation, infections, and immune responses. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-PAD cells exhibit regenerative potential due to their capacity to release factors in response to chemical distress signals from tissues that have been damaged by muscle trauma or inflammation. These therapeutic factors trigger the body’s repair mechanisms and stimulate tissue renewal, differentiation and modulation of immune-mediated ...
Manufactured by:Nano Intelligent Biomedical Engineering Corporations (NIBEC) Co., Ltd. based inJincheon-gun, SOUTH KOREA
Manufactured by removing organic components and purifying only inorganic bone mineral, OCS-H has a low rate of inflammation and immune rejection. It is a biocompatible bone graft material that is made from equine bone, of which structure is almost the same as human bone, so that it can be easily compatible with surrounding bone tissue when grafted. OCS-H bone ...
Manufactured by:Itamar Medical Ltd. based inAtlanta, GEORGIA
What if you could identify high risk patients at the earliest stage of their cardiovascular disease - would you treat them differently? The EndoPAT – the only FDA-cleared test for the non-invasive assessment of Endothelial Dysfunction (arterial health); clinically proven by leading cardiologists through prestigious peer-reviewed studies as a valuable tool in cardiovascular risk ...